Johnson & Johnson has announced European approval for eligible multiple myeloma patients or caregivers to self-administer DARZALEX® from the fifth dose onwards.
Read more
Gilead Sciences and Kite have announced the reimbursement of two CAR T-cell therapies in Ireland for eligible adult patients with certain relapsed or refractory blood cancers.
Read more
Gilead Sciences and Kite have confirmed that Tecartus (brexucabtagene autoleucel), the first CAR T therapy for relapsed or refractory adult B-cell precursor acute lymphoblastic leukaemia, is now reimbursed in Ireland, offering a personalised treatment option supported by pivotal ZUMA-3 trial data.
Read more
Introduction: In the ever-evolving world of cancer care, staying informed is crucial The Irish Haematology Oncology Podcast is your go-to resource
Read more
Background: Anticoagulants are frequently prescribed medications. In Ireland, direct oral anticoagulants are the anticoagulants of choice in most cases but
Read moreThe Novus test, SepTec, analyses blood samples and diagnoses life-threatening bloodstream infections in just 15 minutes Deal brings to
Read more
Background: Venous Thromboembolism (VTE) is a leading cause of maternal death in the developed world. 1 Although a rare event,
Read more
Written by Dr Deirdre Lundy, Clinical Lead, Complex Menopause Service, NMH, Holles St Levels of female reproductive hormone will start
Read more
Authors: Dr Katie Liston and Dr Ciara O’Rafferty, Department of Haematology, Tallaght University Hospital, Dublin The epidemiology and relevance of
Read more
Written by Dr Stuart Macleod & Dr Barry Kevane, Department of Haematology, Mater Misericordiae University Hospital, Dublin Introduction Venous Thromboembolism
Read more